1-3 of 3
Montreh Tavakkoli
Close
Sort by
Journal Articles

Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis

Clinical Trials & Observations
Narendranath Epperla, Qiuhong Zhao, Tamara Moyo, Marcus P. Watkins, Montreh Tavakkoli, Celeste Bello, Pallawi Torka, Nishitha Reddy, Colin Thomas, Kaitlin Annunzio, Beth Christian, Stefan K. Barta, Geoffrey Shouse, Adam J. Olszewski, Nancy L. Bartlett
Journal: Blood Advances
Blood Adv (2024) 8 (3): 549–552.
https://doi.org/10.1182/bloodadvances.2023011698
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Clinical Trials & Observations
Kaitlin Annunzio, Natalie S. Grover, Rina Li Welkie, Pallawi Torka, Marcus P. Watkins, Andrea Anampa-Guzmán, Montreh Tavakkoli, Timothy S. Oh, Heather Reves, Daniel Jones, Walter Hanel, Beth Christian, Praveen Ramakrishnan Geethakumari, Reem Karmali, Stefan K. Barta, Nancy L. Bartlett, Adam J. Olszewski, Narendranath Epperla
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6839–6843.
https://doi.org/10.1182/bloodadvances.2023011288
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

Clinical Trials & Observations
Narendranath Epperla, Qiuhong Zhao, Reem Karmali, Pallawi Torka, Lauren Shea, Timothy S. Oh, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Irl Brian Greenwell, Emily Hansinger, Elvira Umyarova, Kaitlin Annunzio, Yazeed Sawalha, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Natalie S. Grover, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5038–5046.
https://doi.org/10.1182/bloodadvances.2023010133
Published: 2023
Includes: Supplemental data